Ticker Scorecard - AMRN Basics Company: Amarin Corporation plc IPO Date: April 1, 1993 Sector: Healthcare Industry: Biotech Market Cap: $242.32M Activated in VL: True Average Daily Range Avg Daily Range: $0.15 | 3.52% Avg Daily Range (30 D): $0.02 | 3.48% Avg Daily Range (90 D): $0.02 | 3.67% Institutional Daily Volume Avg Daily Volume: 2.75M Avg Daily Volume (30 D): .93M Avg Daily Volume (90 D): 1.22M Trade Size Avg Trade Size (Sh.): 299 Avg Trade Size (Sh.) (30 D): 396 Avg Trade Size (Sh.) (90 D): 553 Institutional Trades Total Inst.Trades: 4,766 Avg Inst. Trade: $1.27M Avg Inst. Trade (30 D): $1.38M Avg Inst. Trade (90 D): $1.38M Avg Inst. Trade Volume: .13M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $1.48M Avg Closing Trade (30 D): $.8M Avg Closing Trade (90 D): $.8M Avg Closing Volume: 133.01K     News Dec 13, 2024 @ 2:00 PM Amarin Appoints Peter Fishman Chief Financial Offi... Source: N/A Jun 4, 2024 @ 11:30 AM Amarin Board of Directors Announces CEO Transition... Source: Amarin Corporation plc May 28, 2024 @ 12:15 PM  Amarin Receives National Reimbursement for VAZ... Source: Amarin Corporation plc May 6, 2024 @ 12:00 PM Amarin to Present at H.C. Wainwright 2nd Annual Bi... Source: Amarin Corporation plc May 3, 2024 @ 1:57 PM Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipe... Source: Zacks Equity Research Financials   TTM Q3 2024 Q2 2024 Basic EPS $-.1 $-.06 $ Diluted EPS $-.1 $-.06 $ Revenue $ 241.02M $ 42.3M $ 67.49M Gross Profit $ 136.07M $ 16.28M $ 42.77M Net Income / Loss $ -39.35M $ -25.13M $ 1.52M Operating Income / Loss $ -44.11M $ -25.17M $ -.52M Cost of Revenue $ 104.95M $ 26.02M $ 24.72M Net Cash Flow $ -113.87M $ -58.98M $ 1.98M PE Ratio     Splits Jan 18, 2008:   10:1